INO wants to pop شراء

Inovio Pharmaceuticals, Inc.NASDAQ

الوصف

⋅ ١٤ تشرين الأول أكتوبر ٢٠١٧ ٢٠:٥٩

INO is revealing head and neck cancer data on November 8-12
It is currently sitting on its 50 day EMA and a past resistance/support level.
Entry: 6.24
Stop Loss: 5.80
Profit Target: 7.00, maybe more

المزيد